Regulatory
August 30, 2023
Regulatory
June 30, 2023
First ten HER2-low patients dosed in Phase 2 basket trial using Affibody’s PET imaging agent ABY-025
Regulatory
March 18, 2023
Regulatory
March 7, 2023
Affibody Medical Investor Relations
Regulatory
August 30, 2023
Regulatory
June 30, 2023
First ten HER2-low patients dosed in Phase 2 basket trial using Affibody’s PET imaging agent ABY-025
Regulatory
March 18, 2023
Regulatory
March 7, 2023